Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| UCLA Prostate Cancer Index× | Vēža bažu skala: Psiholoģiskā diskomforta mērīšana vēža aprūpē× | |
|---|---|---|
| Nozare | Onkoloģija | Onkoloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1998 | 1991 |
| Autors≠ | Litwin, M. S., et al. | Lerman, C., et al. |
| Tips | Self-report questionnaire | Self-report questionnaire |
| Pirmavots≠ | Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998). The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care, 36(7), 1002–1012. DOI ↗ | Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychol, 10(1), 259–267. DOI ↗ |
| Citi nosaukumi≠ | UCLA PCI, PCI | CWS |
| Saistītās | 5 | 5 |
| Kopsavilkums≠ | The UCLA Prostate Cancer Index (UCLA PCI) is a 20-item, prostate-cancer-specific quality-of-life instrument focused on functional outcomes (urinary, sexual, bowel) rather than general cancer QoL. Developed by Litwin et al. in 1998, it has become the standard functional assessment tool in prostate cancer outcomes research, particularly for treatment comparison studies evaluating surgical vs. radiation outcomes. | The Cancer Worry Scale (CWS) is a brief 8-item instrument assessing the degree to which cancer-related worry interferes with daily functioning and emotional well-being. Developed by Lerman et al. in 1991, it quantifies cancer-related anxiety and distress—psychological burden distinct from symptom burden and functional impairment. It is widely used in cancer screening, treatment, and survivorship contexts to identify patients requiring psychological support. |
| ScholarGateDatu kopa ↗ |
|
|